Cholesterol-LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis
{{output}}
Metabolic dysfunction-associated steatotic liver disease is increasing worldwide, and its progression to metabolic dysfunction-associated steatohepatitis (MASH) and ultimately hepatocellular carcinoma (HCC) remains a major clinical challenge. In this review, w... ...
